GSEP
PYPD icon

Golden State Equity Partners’s PolyPid PYPD Stock Holding History

Golden State Equity Partners’s Portfolio PYPD Stock Details PYPD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-90
Closed -$309 – 756
2024
Q3 		$309 Buy
+90
New +$323 ﹤0.01% 790

Other funds holding PYPD

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Golden State Equity Partners's PYPD Position: Q4 2024 in Review

Golden State Equity Partners sold out of PolyPid (PYPD) in Q4 2024, closing a stake of 90 shares — an estimated $309 sold.

Golden State Equity Partners first reported a position in PYPD in Q3 2024 and held it in 1 quarter. The position peaked at $309 in Q3 2024. 14 funds tracked by Wall St. Rank hold PYPD as of Q4 2024.

  • Golden State Equity Partners reported no remaining PolyPid position as of Q4 2024 after selling out during the quarter.
  • Golden State Equity Partners sold 90 PolyPid shares in Q4 2024, an estimated $309.
  • Golden State Equity Partners first reported a position in PolyPid in Q3 2024 and held it in 1 quarter.
  • Golden State Equity Partners's PolyPid position peaked at $309 in Q3 2024.
  • 14 funds tracked by Wall St. Rank held PolyPid as of Q4 2024.

Based on Golden State Equity Partners's 13F filing for Q4 2024, filed 24 Jan 2025.